Newsletter promoters LOVE dates — using a specific day in the calendar, preferably a day within the next month or two, gives a sense of urgency to an ad and makes you feel like you have to sign up RIGHT NOW to avoid missing out on the profits that can be made. And Agora is […]
This week I’ve got a little teaser decipherization for you to get us started, and we’ve also got a new piece from Dr. KSS… and I’ve got some updated thoughts on a few other stocks at the end of today’s piece. The teaser? Well, it’s been circulating for a few weeks now, and it caught […]
Another biotech teaser for you today — these never seem to stop, perhaps partly because small biotech stocks are almost the only ones, other than little junior miners, that have a legitimate chance of seeing their prospects change dramatically overnight or see rapid 100%, 200%, 500% share price gains on a new discovery or shockingly […]
I know I’ve said this before, and sometimes it’s a lie: I’m going to try to keep this one brief. Agora Financial’s FDA Trader service has a new pitch out — which normally might not get that much attention, since everyone is suddenly terrified of biotech stocks after a brutal month or two — but […]
This is a quickie for you, I came across it and don’t want to write up a full look at the company but I thought some of you would like the teaser solution. The ad’s from Agora Financial’s FDA Trader, which has been touting this “magic calendar” idea of investing in stocks around (mostly) PDUFA […]
That’s right, the end of obesity. That’s what’s being touted by the new letter that as far as I can tell was just launched moments ago by Agora, which they’re calling FDA Trader and for which they apparently hired away Paul Mampilly from the Palm Beach Letter (OK, they didn’t really “hire him away” — […]
Biotech trading advisory/newsletter.